Array is a biopharmaceutical company that researches, develops and commercializes targeted small molecule medicines to treat cancer... Read more
Array is a biopharmaceutical company that researches, develops and commercializes targeted small molecule medicines to treat cancer... Read more
CEO
Add
News
May 26, 2023
The Business Journals
Array BioPharma: Founder of multi-billion dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing round
Feb 27, 2023
Bloomberg Law
Array BioPharma: Attorney Fees of $2.83 Million Upheld in Array BioPharma Suit
May 24, 2021
MarketScreener
Array BioPharma: Notice of Proposed Class Action Settlement Involving All Persons or Entities who Purchased or Otherwise Acquired Array Biopharma, Inc. Common Stock
Apr 29, 2021
Law 360
Array BioPharma: Array Biopharma, Investors Agree T0 $8.5M Settlement Deal
Aug 01, 2019
FinSMEs
Array BioPharma: Pfizer Closes Acquisition of Array BioPharma
Jul 30, 2019
BioSpace
Array BioPharma: Pfizer Completes Acquisition of Array Biopharma
Jul 09, 2019
4-traders
Array BioPharma: Legal Investigation Alert: Halper Sadeh LLP Continues Investigating Whether the Sale of Array BioPharma Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - ARRY
Jul 08, 2019
FiercePharma
Array BioPharma: Array's colorectal cancer data shows why Pfizer splashed out $11B for the biotech
Jul 08, 2019
PharmaLive
Array BioPharma: Array BioPharma's Triple-Drug Combo Could be Gamechanger for Colorectal Cancer
Jul 08, 2019
The Pharma Letter
Array BioPharma: Positive Phase III data for Pierre Fabre and Array BioPharma
Array BioPharma Competitors
1
2
3
4
5
6
7
8
9
10